Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy.
Kentaro OhuchiRyo AmagaiErika TamabuchiYumi KanbayashiTaku FujimuraPublished in: The Journal of dermatology (2022)